Figure 5
From: Genotyping panel for assessing response to cancer chemotherapy
Genotyping for UGT1A1 promoter (TA)nTAA dinucleotide repeat polymorphism. The three samples are (TA)6/7TAA heterozygous, and (TA)7/7TAA and (TA)6/6TAA homozygous.
Figure 5 | BMC Medical Genomics